Walking-While-Talking Test versus Stops-Walking-When- Talking Test on predicting risk of falls in stroke survivors
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Manipal University
- Enrollment
- 52
- Locations
- 1
- Primary Endpoint
- Berg Balance Scale
Study Overview
Brief Summary
Independently ambulating stroke patients will be selected forthe study.
Eachsubject will be assessed using 3 fall prediction tools i.e. Berg Balance Scale, Walking While Talking Test, Stops Walking WhenTalking Test and 1 questionnaire-Falls Efficacy Questionnaire. The assessment will be conducted as per the standard procedurewhich involves randomly assigning the 3 tests and 1 questionnaire to eachpatient. The tests shall be administered with 5 minute rest periods in between.Throughout the procedure, for safety purpose, manual assistance/support will beprovided by 2 physiotherapists by staying in close proximity to the patient.
• Berg Balance Scale: Scores will be givenaccording to the criteria described by Berg et al.
• Falls Efficacy Scale: A questionnairewill be handed to the patient to fill and scoring will be given by the testerusing the criteria described by Tinetti et al.
• Walking While Talking Test: The scoringwill be time based.
• Stops Walking When Talking Test: The testwould be considered positive if patient stops walking when the evaluatorinitiates a conversation.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18.00 Year(s) to 99.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •First episode of stroke Clinically stable patient MOCA Score-26 and above Any ambulatory stroke survivor.
Exclusion Criteria
- •Patients with any visual impairments.
- •Patients with any other neurological conditions.
- •Patients with any musculoskeletal disorders.
Outcomes
Primary Outcomes
Berg Balance Scale
Time Frame: One time measurement at the time of recruitment
Falls Efficacy Questionnaire
Time Frame: One time measurement at the time of recruitment
Secondary Outcomes
- Risk of Falls(Baseline)